drugset / Trial / NCT02704962

Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine

NCT02704962

RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators hypothesis is that an antipsychotic drug combination of low-dose olanzapine plus low-dose trifluoperazine is similar to regular-dose olanzapine monotherapy in efficacy and safety for treatment of schizophrenia.The goal of this study is to compare the efficacy and safety of the olanzapine (10 mg/d) and olanzapine (5 mg/d) plus trifluoperazine (5 mg/d) in the treatment of acute psychotic exacerbations of schizophrenia.

Timeline

Start
2012-01
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule 5 mg
Subject Olanzapine Small molecule 10 mg
Subject full-dose olanzapine Unknown 5 mg

Indications